Cardiol 2000;75(Suppl 1):S21-33; discussion: S35-6.
36. Koster MJ, Matteson EL, Warrington KJ. Recent advances in
the clinical management of giant cell arteritis and
Takayasu arteritis. Curr Opin Rheumatol 2016;28:211-7.
37. Moral S, Cuéllar H, Avegliano G, Ballesteros E, Salcedo MT,
Ferreira-González I, et al. Clinical implications of focal
intimal disruption in patients with type B intramural hematoma. J Am Coll Cardiol 2017;69:28-39.
38. Chou AS, Ziganshin BA, Charilaou P, Tranquilli M, Rizzo JA,
Elefteriades JA. Long-term behavior of aortic intramural
hematomas and penetrating ulcers. J Thorac Cardiovasc
Surg 2016;151:361-72.
39. Eggebrecht H, Plicht B, Kahlert P, Erbel R. Intramural
hematoma and penetrating ulcers: indications to endovascular treatment. Eur J Vasc Endovasc Surg 2009;38:
659-65.
40. Macedo TA, Stanson AW, Oderich GS, Johnson CM,
Panneton JM, Tie ML. Infected aortic aneurysms: imaging
ﬁndings. Radiology 2004;231:250-7.
41. Riesenman PJ, Brooks JD, Farber MA. Thoracic endovascular aortic repair of aortobronchial ﬁstulas. J Vasc Surg
2009;50:992-8.
42. Hoffman JL, Gray RG, Minich LL, Wilkinson SE, Heywood M,
Edwards R, et al. Screening for aortic aneurysm after
treatment of coarctation. Pediatr Cardiol 2014;35:47-52.
43. Lala S, Scali ST,